Solvay stock enters Q3 results with Saudi recovery options in focus
Published on 11/03/2026 at 18:04 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey issues before full results
- Solvay cut its 2026 underlying EBITDA outlook to EUR 720 million to EUR 740 million after Middle East disruption.
- The Sadara peroxide shutdown reduced third-quarter underlying EBITDA by nearly EUR 15 million.
- Full third-quarter results are scheduled for Wednesday, November 4.
Solvay enters the final session before its full third-quarter report with investors focused on recovery options linked to its Saudi joint venture. Reuters reported on October 19 that the Middle East conflict and the shutdown of a peroxide plant at the Sadara complex weighed on preliminary results.
Solvay stock traded at 23.58 euros on Lang & Schwarz at 5:58 p.m. CET on Tuesday, November 3, 2026, down 1.42 percent from the 23.92 euros quoted in the November 2 report. The real-time quote of Solvay stock provides the latest trading indication.
Saudi disruption shapes outlook
Solvay's preliminary third-quarter underlying sales reached EUR 1.03 billion, while underlying EBITDA was EUR 173 million. Free cash flow to shareholders from continuing operations amounted to EUR 54 million.
The company said the Middle East conflict reduced third-quarter underlying EBITDA by approximately EUR 25 million, including nearly EUR 15 million from the continued shutdown of the Sadara peroxide plant in Jubail, Saudi Arabia. Solvay is examining contractual mechanisms that could help recover lost profitability through the joint venture.
Solvay lowered its 2026 underlying EBITDA guidance to EUR 720 million to EUR 740 million from EUR 770 million to EUR 850 million. The revised outlook excludes potential revenue or recovery measures from Sadara for the rest of the year and includes free cash flow guidance of EUR 120 million to EUR 150 million, net of approximately EUR 90 million in transformation expenses.
Results are the next catalyst
Complete third-quarter results are scheduled for Wednesday, November 4. The release should show whether the preliminary figures remain unchanged after the quarter-end closing process and provide a fuller view of divisional performance, cash generation and the Saudi operations.
Reuters reported the guidance reset on Euronext's publication of the Reuters report.
Solvay stock facts
- Company: Solvay S.A.
- ISIN: BE0003470755
- Lang & Schwarz quote: 23.58 euros on November 3, 2026 at 5:58 p.m. CET
- Preliminary Q3 underlying EBITDA: EUR 173 million
- 2026 underlying EBITDA guidance: EUR 720 million to EUR 740 million
Investors can follow broader developments through current market reports.
